America's Best Nonprofits
  1. Home
  2. Disease & Disorders
  3. Cincinnati, OH
  4. Smith-Kingsmore Syndrome Foundation

Smith-Kingsmore Syndrome Foundation

Smith-Kingsmore Syndrome Foundation has an America's Best Score of 51 out of 100, based on its 2025 Form 990, below the 60-point bar to be ranked.

  • Cincinnati, OH
  • Tax-exempt since 2020
  • EIN: 84-2913037
smithkingsmore.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
51OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Smith-Kingsmore Syndrome Foundation is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G80). Contributions are tax-deductible.

2722 Erie Ave Ste 219 Pmb 683837, Cincinnati, OH 45208-2154

Among the 20 scored disease & disorders organizations in Cincinnati, Smith-Kingsmore Syndrome Foundation holds 19.6 months of operating reserves (peer median 14.6 months), runs a typical yearly deficit of 50.7% (peers: surplus of 0.8%), and has cut spending 14.1% a year (peers: grown spending 6.3% a year).

In fiscal year 2025 it reported $168,029 in revenue and $165,899 in expenses, with contributions making up 99.1% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Fund research to better understand Smith-Kingsmore syndrome and find treatments to improve patient quality of life and, ultimately, a cure.

Main program · fiscal year 2025

  • This year, Smith-Kingsmore Syndrome Foundation advanced its mission with a comprehensive scientific strategy and participation in key conferences to strengthen ties with the research and clinical community. We launched a multi-year drug repurposing initiative in Dr. Joanna Chius laboratory at the University of California: Davis, building on prior Foundation-funded work modeling SKS phenotypes and… Read more

    This year, Smith-Kingsmore Syndrome Foundation advanced its mission with a comprehensive scientific strategy and participation in key conferences to strengthen ties with the research and clinical community. We launched a multi-year drug repurposing initiative in Dr. Joanna Chius laboratory at the University of California: Davis, building on prior Foundation-funded work modeling SKS phenotypes and screening FDA-approved compounds; funded through the next two fiscal years, this is a major step toward identifying treatment options for individuals with SKS. We also began cataloging all known SKS variants to enhance understanding of genotypephenotype relationships and continued hosting events connecting families, clinicians, and researchers to advance progress toward effective treatments.

    $116,864 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 70¢ went to programs, 10¢ to management and 20¢ to fundraising.

  • Programs $116,864
  • Management $15,387
  • Fundraising $33,648

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score51 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves19.6 mo; 19.5 mo in cash13.6 / 25
Financial balance (median margin)−50.7%5 / 20
Transparency3 full 990s, latest TY202520 / 20
Program growth−14.1% / yr0.5 / 15
Track record6 years2.4 / 10
Debt load0.0% of assets10 / 10
Total51.5 → 51
Spending on programs
Not scored; America's Best needs 65%+
70%Meets

Compared with Cincinnati peers

MeasureThis organizationPeer median
Operating reserves19.6 mo14.6 mo
Typical margin−50.7%+0.8%
Spending growth−14.1% / yr+6.3% / yr
Debt load0.0%2.0%

Peers: the 20 Cincinnati disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$168,029Fiscal year 20252023: $74,75020232024: $172,22920242025: $168,0292025
Expenses$165,899Fiscal year 20252023: $224,70620232024: $349,41020242025: $165,8992025
Total assets$271,115Fiscal year 20252023: $509,15020232024: $275,60020242025: $271,1152025
Total liabilities$0Fiscal year 20252023: $62,98420232024: $6,61520242025: $02025
Fiscal year ending June 2025
Revenue$168,029
Expenses$165,899
Net income$2,130
Net assets$271,115

Notable sources of revenue

Percent of total revenue
Contributions$166,500
Program services$0
Investment income$1,487
Other (net)$42

Assets / debt

Total assets$271,115
Total liabilities$0
Net assets$271,115

Compensation

Not in our extract for this year.

Fiscal year ending June 2024
Revenue$172,229
Expenses$349,410
Net income−$177,181
Net assets$268,985

Notable sources of revenue

Percent of total revenue
Contributions$171,540
Program services$0
Investment income$578
Other (net)$111

Assets / debt

Total assets$275,600
Total liabilities$6,615
Net assets$268,985

Compensation

Not in our extract for this year.

Fiscal year ending June 2023
Revenue$74,750
Expenses$224,706
Net income−$149,956
Net assets$446,166

Notable sources of revenue

Percent of total revenue
Contributions$74,563
Program services$0
Investment income$0
Other (net)$187

Assets / debt

Total assets$509,150
Total liabilities$62,984
Net assets$446,166

Compensation

Officers and key employees$81,865
Share of expenses36.4%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?